These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21712710)

  • 21. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR; Feuerstein GZ
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-agonists, beta-blockers and obstructive airway disease.
    Madalena Esteves M
    Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
    [No Abstract]   [Full Text] [Related]  

  • 23. [Beta blockers in therapy of chronic heart failure].
    Hoffman J; Grimm W; Maisch B
    Herz; 2002 Mar; 27(2):150-65. PubMed ID: 12025460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-adrenergic blockers in heart failure: review of mechanisms of action and clinical outcomes.
    Satwani S; Dec GW; Narula J
    J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):243-55. PubMed ID: 15678243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism.
    Hanania NA; Dickey BF; Bond RA
    Curr Opin Pulm Med; 2010 Jan; 16(1):1-5. PubMed ID: 19887938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do beta-blockers have a role in patients with congestive heart failure?
    Eichhorn EJ
    Cardiol Clin; 1994 Feb; 12(1):133-42. PubMed ID: 7910113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of beta-blockade therapy in treatment of congestive heart failure.
    Sobotka PA; Gunnar RM
    Clin Cardiol; 1992 Sep; 15(9):630-5. PubMed ID: 1356677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
    Silke B; Guy S; Riddell JG
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-blockade in heart failure: selective versus nonselective agents.
    Metra M; Nodari S; Dei Cas L
    Am J Cardiovasc Drugs; 2001; 1(1):3-14. PubMed ID: 14728047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta-adrenoceptor blockers as agonists: coupling of beta2-adrenoceptors to multiple G-proteins in the failing human heart.
    Harding SE; Gong H
    Congest Heart Fail; 2004; 10(4):181-5; quiz 186-7. PubMed ID: 15314476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.
    Salpeter SR; Ormiston TM; Salpeter EE
    Chest; 2004 Jun; 125(6):2309-21. PubMed ID: 15189956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of cardiac function and beta-adrenergic signal transduction by propionyl L-carnitine in congestive heart failure due to myocardial infarction.
    Sethi R; Wang X; Ferrari R; Dhalla NS
    Coron Artery Dis; 2004 Feb; 15(1):65-71. PubMed ID: 15201623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists.
    Emilien G; Maloteaux JM
    Eur J Clin Pharmacol; 1998 Feb; 53(6):389-404. PubMed ID: 9551698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effect of the central nervous system beta-adrenoceptor blockade on the failing heart.
    Gourine A; Bondar SI; Spyer KM; Gourine AV
    Circ Res; 2008 Mar; 102(6):633-6. PubMed ID: 18323523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of adrenoceptors in circulatory and metabolic regulation.
    Van Zwieten PA
    Am Heart J; 1988 Nov; 116(5 Pt 2):1384-92. PubMed ID: 2903648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic infusion of beta-adrenoceptor antagonist and inverse agonists decreases elevated protein kinase A activity in transgenic mice with cardiac-specific overexpression of human beta 2-adrenoceptor.
    Liu X; Callaerts-Vegh Z; Evans KL; Bond RA
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):448-55. PubMed ID: 12198331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of beta-adrenergic agents on systolic and diastolic myocardial function in patients with and without heart failure.
    Colucci WS; Parker JD
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S28-37. PubMed ID: 2478807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of clenbuterol on contractility and Ca2+ homeostasis of isolated rat ventricular myocytes.
    Siedlecka U; Arora M; Kolettis T; Soppa GK; Lee J; Stagg MA; Harding SE; Yacoub MH; Terracciano CM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H1917-26. PubMed ID: 18775853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure.
    Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Feb; 374(5-6):361-72. PubMed ID: 17216434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac adrenoceptors in the failing heart: effect of intervention.
    Fowler MB
    Eur Heart J; 1990 Apr; 11 Suppl A():13-8. PubMed ID: 1971585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.